TABLE 2.
Model | Covariate(s) | ΔOFV | BSVCL | BSVV | RUVσprop | RUVσadd |
---|---|---|---|---|---|---|
Base | None | 0 | 43.6 | 30.5 | 36.3 | 1.41 |
1 | Size on CL | −157 | 30.3 | 28.9 | 32.6 | 1.57 |
2 | PMA on CL | −276 | 33.3 | 28.8 | 27.5 | 1.82 |
3 | SCR on CL | −227 | 36.9 | 29.4 | 27.4 | 2.09 |
4 | PNA on CL | −204 | 38.5 | 31.8 | 29.3 | 1.74 |
5 | Ventilation on CL | −56 | 40.9 | 31.2 | 35.9 | 1.67 |
6 | SGA on CL | 0 | 43.4 | 30.5 | 36.3 | 1.41 |
7 | NSAID on CL | 0 | 43.5 | 31.2 | 36.3 | 1.99 |
8 | Race on CL | −5 | 44.4 | 30.3 | 36.2 | 1.45 |
9 | Size on V | −12 | 45.3 | 6.4 | 31.8 | 2.32 |
10 | Size and PMA on CL; size on V | −449 | 23.3 | 12.0 | 23.0 | 1.52 |
12 | Size, PMA, and race on CL; size on V | −458 | 23.1 | 12.5 | 23.0 | 1.52 |
13 | Size, PMA, and SCR on CL; size on V | −426 | 23.1 | 10.8 | 22.9 | 2.18 |
Final | Size, PMA, and SGA on CL; size on V | −519 | 20.5 | 12.6 | 22.9 | 1.51 |
ΔOFV, change in objective function values; BSV, between-subject variability; RUVσprop, unexplained residual variability (proportional); RUVσadd, unexplained residual variability (additive); SCR, serum creatinine concentration.